GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » EV-to-EBIT

Enhabit (Enhabit) EV-to-EBIT : -22.77 (As of May. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enhabit EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Enhabit's Enterprise Value is $1,079 Mil. Enhabit's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-47 Mil. Therefore, Enhabit's EV-to-EBIT for today is -22.77.

The historical rank and industry rank for Enhabit's EV-to-EBIT or its related term are showing as below:

EHAB' s EV-to-EBIT Range Over the Past 10 Years
Min: -135.09   Med: -9.24   Max: 13.23
Current: -22.77

During the past 5 years, the highest EV-to-EBIT of Enhabit was 13.23. The lowest was -135.09. And the median was -9.24.

EHAB's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.66 vs EHAB: -22.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Enhabit's Enterprise Value for the quarter that ended in Dec. 2023 was $1,133 Mil. Enhabit's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-47 Mil. Enhabit's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.18%.


Enhabit EV-to-EBIT Historical Data

The historical data trend for Enhabit's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enhabit EV-to-EBIT Chart

Enhabit Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -123.35 -23.90

Enhabit Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -123.35 -41.29 -8.88 -8.24 -23.90

Competitive Comparison of Enhabit's EV-to-EBIT

For the Medical Care Facilities subindustry, Enhabit's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enhabit's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enhabit's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Enhabit's EV-to-EBIT falls into.



Enhabit EV-to-EBIT Calculation

Enhabit's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1079.242/-47.4
=-22.77

Enhabit's current Enterprise Value is $1,079 Mil.
Enhabit's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enhabit  (NYSE:EHAB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Enhabit's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-47.4/1132.75269
=-4.18 %

Enhabit's Enterprise Value for the quarter that ended in Dec. 2023 was $1,133 Mil.
Enhabit's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enhabit EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Enhabit's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Enhabit (Enhabit) Business Description

Traded in Other Exchanges
Address
6688 N. Central Expressway, Suite 1300, Dallas, TX, USA, 75206
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Executives
Jeffrey Bolton director 1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901
Shaw L Edward Jr director AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156
Stuart M Mcguigan director 74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902
Barry P. Schochet director 100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011
Dylan C Black officer: General Counsel and Secretary 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Langham Ronald Leroy Jr officer: EVP Clinical Excel. & Strategy 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Gregory S Rush director TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302
Tina L. Brown-stevenson director 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Erin Hoeflinger director 511 FALLVIEW COURT, SPRINGBORO OH 45066
Tanya Renee Marion officer: Chief Human Resources Officer 6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Charles M Elson director 1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707
Barbara Ann Jacobsmeyer director, officer: President and CEO 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Maupin John E Jr D D S director 103 POWELL COURT SUITE 200, BRENTWOOD TN 37027